FMS (Fresenius Medical Care AG) Stock Analysis - Analyst Ratings

Fresenius Medical Care AG (FMS) is a publicly traded Healthcare sector company. As of May 20, 2026, FMS trades at $22.21 with a market cap of $11.94B and a P/E ratio of 0.00. FMS moved +0.43% today. Year to date, FMS is -6.64%; over the trailing twelve months it is -25.63%. Its 52-week range spans $18.94 to $30.46. Analyst consensus is neutral with an average price target of $26.00. Rallies surfaces FMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate FMS?

1 analysts cover FMS: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $26.00.

FMS Key Metrics

Key financial metrics for FMS
MetricValue
Price$22.21
Market Cap$11.94B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.87%
52-Week High$30.46
52-Week Low$18.94
Volume601.52K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

FMS Analyst Consensus

1 analysts cover FMS: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $26.00.

Latest FMS News

Common questions about FMS

What do analysts rate FMS?
1 analysts cover FMS: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $26.00.
Does Rallies show FMS price targets?
Yes. Rallies tracks FMS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is FMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FMS. It does not provide personalized investment advice.
FMS

FMS